1trader - yes I think it is. Plus the $700m.
Management are going to need to re-evaluate how to reduce the cash costs. They may have the advatage in no rail, but the costs are not standing out. This is only the PFS, so it is not final and allot of work is needed before the DFS.
Further dilution is worry for the future.
I have 50c as the next support and that may be a real possibilty imo.
- Forums
- ASX - By Stock
- PLV
- npv 4x current sp, phase 1 only!!
npv 4x current sp, phase 1 only!!, page-13
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PLV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online